32 Biosciences

32 Biosciences

Early Stage

Diversified life science company focused on Gut Microbiome medicine

Diversified life science company focused on Gut Microbiome medicine

Overview

Raised this Round: Raised: $90,150

Total Commitments ($USD)

Platform

Republic

Start Date

06/23/2024

Close Date

10/22/2024

Min. Goal
$50,000
Max. Goal
$1,235,000
Min. Investment

$300

Security Type

SAFE

Series

Seed

SEC Filing Type

RegCF    Open SEC Filing

Valuation Cap

$31,250,000

Discount

20%

Year Founded

2023

Industry

Healthcare & Pharmaceuticals

Tech Sector

HealthTech

Distribution Model

B2B

Margin

High

Capital Intensity

High

Location

Illinois, Illinois

Business Type

High Growth

32 Biosciences, with a valuation of $31.25 million, is raising funds on Republic. It is a diversified life science company focused on harnessing microbiome science to prevent and treat diseases. 32 Biosciences is taking a new approach to medicine to build clinically useful and validated tools to diagnose and correct Dysbiosis or microbiome imbalance. The offerings of 32 Biosciences include a gut microbiome diagnostic tool and targeted microbiome therapeutics and has collaborations with academic institutions and business partners. John Alverdy, Eugene B. Chang, and Joseph F. Pierre founded 32 Biosciences in June 2023. The current crowdfunding campaign has a minimum target of $50,000 and a maximum target of $1.24 million. The campaign proceeds will be used for research and development, operations, manufacturing, and regulatory expenses.

Summary Profit and Loss Statement

FY 2023 FY 2022

Revenue

$0

$0

COGS

$0

$0

Tax

$0

$0

 

 

Net Income

$3,111

$0

Summary Balance Sheet

FY 2023 FY 2022

Cash

$3,277

$0

Accounts Receivable

$0

$0

Total Assets

$3,227

$0

Short-Term Debt

$116

$0

Long-Term Debt

$0

$0

Total Liabilities

$116

$0

Financials as of: 06/23/2024
Create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Ratings KingsCrowd Startup Rating Methodology Article

Blurred Ratings Bars Blurred Ratings Bars
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.
Add to portfolio
32 Biosciences on Republic 2024
Platform: Republic
Security Type: SAFE
Valuation: $31,250,000

Follow company

Follow 32 Biosciences on Republic 2024

Buy 32 Biosciences's Deal Report

32 Biosciences Deal Report

Get KingsCrowd’s comprehensive report on 32 Biosciences including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether 32 Biosciences is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the 32 Biosciences deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge